Abstract
We showed previously that murine naive CD4+ T cells and TH1 cell clones express the beta2-adrenergic receptor (β2AR), while TH2 cell clones do not. We report here that naive CD4+ T cells that differentiated for 1-5 days under TH1 driving conditions increased β2AR gene expression, while cells cultured under TH2 driving conditions decrease β2AR gene expression. Chromatin immunoprecipitation revealed that the increase in β2AR gene expression in TH1 cells is mediated by an increase in histone 3 (H3) and H4 acetylation, as well as an increase in histone 3 lysine 4 (H3K4) methylation. Conversely, the decrease in β2AR gene expression in TH2 cells is mediated by a decrease in H3 and H4 acetylation and a decrease in H3K4 methylation, as well as an increase H3K9 and H3K27 methylation. The histone changes could be detected as early as 3 days of differentiating conditions. Genomic bisulfite sequencing showed that the level of methylated CpG dinucleotides within the promoter of the β2AR gene was increased in TH2 cells as compared to naive and TH1 cells. Collectively, these results suggest that epigenetic mechanisms mediate maintenance and repression, respectively, of the β2AR gene expression in TH1- and TH2-driven cells, providing a potential mechanism by which the level of β2AR expression might be modulated pharmacologically within immune cells and other cell types in which the expression profile may change during a disease process.
Keywords: Beta2-Adrenergic Receptor, CD4, Epigenetics, TH1, TH2, Histone modifications
Introduction
Th1 cells produce interferon (IFN)-γ to promote effective immune responses that protect the host against the spread of intracellular pathogens, while TH2 cells produce interleukin (IL)-4 to promote effective immune responses that protect the host against the spread of extracellular pathogens (Abbas et al., 1996). The development of an appropriate effector T cell response is, therefore, critical for the maintenance of homeostasis. The cellular activity of naive and effector CD4+ T cells is regulated primarily by cytokines and costimulatory molecules, as well as by neurotransmitters and hormones (Steinman, 2004). The neurotransmitter norepinephrine is stored in sympathetic nerve terminals that reside within the parenchyma of lymphoid tissue (Kohm et al., 2000) and are in close association with CD4+ T cells (Felten et al., 1998; Felten and Olschowka, 1987). Norepinephrine is released from these nerve terminals after antigen enters the system and binds to the beta2-adrenergic receptor (β2AR) that is expressed on immune cells. Engagement of the β2AR on an immune cell regulates cellular activity in a cAMP- and PKA-dependent manner (Kohm and Sanders, 2001). Although it was thought that the β2AR was expressed on all CD4+ T cells, we now know that CD4+ T cell naive and TH1 cells express the β2AR, while the TH2 cells do not, as assessed by radioligand binding, immunofluorescence analysis, agonist-induced intracellular cAMP accumulation, and/or reverse transcription-PCR (Ramer-Quinn et al., 1997; Sanders et al., 1997; Swanson et al., 2001). Upon CD4+ T cell activation in the presence of a β2AR agonist, the level of IL-2 and IFN-γ production by naive CD4+ T cells and Th1 cells changed when compared to activated, but unexposed cells, while the level of IL-4 produced by TH2 cells remained the same (Ramer-Quinn et al., 1997; Sanders et al., 1997; Swanson et al., 2001), supporting the pharmacologic and molecular data that a functional β2AR was expressed on naive and TH1 cells, but not TH2 cells. Thus, the collective findings suggest that an association may exist between the development of TH1 and TH2 cells and their ability to maintain or repress expression of the β2AR gene.
Gene expression is regulated primarily by transcription factors that bind to the gene promoter region. Chromatin remodeling, which results from covalent modifications of histones and DNA, influences eukaryotic gene activity by affecting the accessibility of the chromatin to transcription factors and RNA polymerases. Mechanisms involved in chromatin remodeling within the promoter regions of DNA include methylation of CpG residues and histone acetylation, methylation, phosphorylation, ribosylation, and ubiquitination (Eberharter and Becker, 2002; Jaenisch and Bird, 2003; Mutskov and Felsenfeld, 2004). Specifically, panacetylation of histone 3 (H3) and histone 4 (H4) as well as methylation of either lysine 4, 36, or 79 in H3 (H3K4, H3K36, and H3K79) is associated with transcriptionally active genes, while a lack of acetylation or methylation of lysine 9, 20, or 27 (H3K9, H3K20, H3K27) is associated with transcriptionally repressed genes (Margueron et al., 2005). Such epigenetic mechanisms have been reported in post-developmental CD4+ T cells and appear to regulate the level of gene expression for CD4 and CD8 (Bilic et al., 2006; Taniuchi et al., 2002), TCR alleles (Bergman and Cedar, 2004), IFN-γ (Avni et al., 2002; Chang and Aune, 2007; Eivazova and Aune, 2004; Fields et al., 2002), and IL-4 (Agarwal and Rao, 1998; Avni et al., 2002; Chang and Aune, 2007; Fields et al., 2002; Lee et al., 2002; Makar et al., 2003). Thus, chromatin remodeling plays an intricate role in regulating the expression of genes in each effector CD4+ T cell subset as it develops from a naive CD4+ T cell.
We proposed that chromatin remodeling may also be involved with the maintenance and repression of β2AR gene expression in developing TH1 and TH2 cells, respectively. In the present study, we show for the first time that β2AR gene transcription was differentially regulated in effector CD4+ T cells that were derived from a naive CD4+ T cells activated with either anti-CD3/anti-CD28 or a specific antigen in the presence of IL-12 or IL-4 to promote Th1 and Th2 development, respectively. Moreover, in comparison to naive CD4+ T cells, a lack of histone acetylation, an increase in the level of H3K9 and H3K27 dimethylation, and the methylation of CpG dinucleotides within the proximal promoter region of the β2AR gene occurred specifically in TH2-driven cells, while pan-H3/H4 acetylation and H3K4 dimethylation increased in TH1-driven cells. Thus, our findings show that epigenetic changes such as histone acetylation and methylation along with DNA methylation maintain expression of the β2AR on TH1 cells, but repress expression on TH2 cells.
Methods
Animals
Female pathogen-free Balb/c mice were obtained from Taconic Farms (Germantown, NY), housed in the American Association Accreditation of Laboratory Animal Care (AAALAC)-accredited Animal Research facility at The Ohio State University (Columbus, OH). Mice were housed in microisolator cages and provided autoclaved food and water ad libitum and used between 6-12 weeks of age. All experiments complied with the Animal Welfare Act and the National Institutes of Health (Bethesda, MD) guidelines for the care and use of animals in biomedical research.
T Cell Clones
The specificity and source of all T cell clones have been described previously (Sanders et al., 1997). TH1 cell clones included AR100.9, D1.1, and HDK-1. Th2 cell clones included CDC35, LNT-1, and LNT-4. Viable cells were obtained before use by centrifugation over Lympholyte-M (Cedarlane Laboratories, Ltd. Ontario, Canada) 8-14 days after antigen activation. Clones were maintained in IL-2-containing medium and were used at least 3 days after initial IL-2 exposure. All clones tested negative for the presence of Mycoplasma contamination (Invitrogen, Carlsbad, California). For activated samples, 1 × 107 cells of each T cell clone were stimulated for 8 hrs on plates coated with 5μg/ml hamster anti-mouse CD3 (clone 145-2C11, kindly provided by Dr. William Lee, Wadworth Institute, Albany, NY) prior to RNA and/or DNA isolation.
Isolation of CD4+ T cells
Naive CD4+ T cells were isolated from the spleens of Balb/c mice as described previously (Kohm et al., 2000) with minor changes. Red blood cells were removed with ammonium chloride treatment for 4 min at 37°C and then washed with Hanks Buffered Salt Solution. Naive CD4+ T cells were isolated using the CD4+ CD62L+ T Cell Isolation Kit sorted on an AutoMacs machine following the manufacturer's directions (Miltenyi Biotech). Briefly, following red blood cell lysis, cells were incubated with an antibody cocktail designed to magnetic-bead label non-CD4+ cells. The cells were sorted using the AutoMacs machine and the negative fraction was retained for further incubation with anti-CD62L-coated magnetic beads. The cells were sorted again on the AutoMacs machine and the positive fraction was retained and the purity of CD4+CD62L+ T cells was verified by Flow Cytometry (>95%). Approximately 10×106-10×107 cells were obtained for each experiment.
Enrichment of IL-4+ or IFN-γ+ Cells
Single-cell suspensions of in vitro-differentiated T cells (approximately 50×106) were harvested following the completion of a week of activation. The cells were stimulated for 4hrs with phorbol 12-myristate 13-acetate (PMA, 50mg/ml) and Ionomycin (500ng/ml) (both from Sigma, St. Louis, MO) in the presence of Brefeldin A (1μg/ml) (BD Biosciences, San Jose, CA). Cells were then washed in PBS containing 0.1% BSA and 0.02% sodium azide then fixed and permeabilized using the Cytofix/Cytoperm solution (BD Biosciences) according to manufacturers directions. The cells were then resuspended in 1X Perm/Wash buffer (BD Biosciences) and incubated with either rat anti-mouse IL-4 (clone BVD6-24G2) or rat anti-mouse IFN-γ (clone XMG1.2) (both from eBiosciences, San Diego, CA) for 30 min at 4°C. Following the incubation, the cells were washed twice with 1X Perm/Wash buffer and resuspended in PBS containing 0.1%BSA. The top 10% (MFI) IL-4+ or IFN-γ+ cell populations were sorted using a BD FACSAria flow cytometer for analysis.
TH1/TH2 Culture Conditions
Naive CD4+ T cells were cultured on plates coated with 5μg/ml hamster anti-mouse CD3 (clone 145-2C11) and 1μg/ml hamster anti-mouse CD28 (clone 37.51.3F3) in complete RMPI. To promote TH1 differentiation, cells were activated in the presence of 20-150 U/ml of human recombinant IL-2 (BRB Preclinical Repository, National Cancer Institute), 5ng/ml mouse recombinant IL-12 (eBioscience, San Diego, CA), and 10μg/ml rat anti-mouse IL-4 (clone 11B.11, BRB Preclinical Repository, National Cancer Institute). To promote TH2 differentiation, cells were cultured in the presence of 20-150 U/ml human recombinant IL-2, 10μg/ml mouse recombinant IL-4 (eBioscience), and 5μg/ml rat anti-mouse IFN-γ (clone XGM1.2, eBioscience). For generation experiments, cells were stimulated every 5 days under the same conditions.
Chromatin Immunopreciptitation (ChIP)
ChIP analysis was carried out as described previously (Podojil et al., 2004). Briefly, naive, activated, or sorted cells were collected and fixed with formaldehyde solution. Cells were then lysed in a series of lysis buffers and nuclei were collected and the suspension was sonicated using a Branson sonifier 250 (Emerson, Danbury, CT) to lyse the nuclear membranes and shear the DNA. The collected chromatin was precleared with Protein A/G agarose beads (Oncogene), the beads were removed, and the chromatin was incubated at 4°C overnight with the following antibodies/conditions: rabbit anti-mouse dimethylated H3K9, rabbit anti-mouse dimethylated H3K4, rabbit anti-mouse monomethylated H3K27, rabbit anti-mouse-acetyl-H3, rabbit anti-mouse-acetyl-H4 (all from Millipore), rabbit isotype control (Cell Signaling, 2729S), or no antibody. Immune complexes were precipitated with Protein A/G agarose beads. An input control sample was obtained from the supernatant of either a no antibody or isotype control sample. The samples were adjusted to 0.5% SDS, 100μg/ml RNase A, and 200μg/ml Proteinase K and then incubated at 55°C for 3 hrs followed by an overnight incubation at 65°C to reverse the formaldehyde crosslinks. The DNA was precipitated using phenol-chloroform and then amplified using the Platinum Taq PCRx Enhancer system (Invitrogen) and the following primer set: β2AR-3P (sense) 5’-GCAGCCCCAGATTTCTCTCT-3’ and β2AR-4P (antisense) 5’-GACTCCTGGAAGCTTCATTCA-3’ to amplify the promoter region -248 to 105.
Bisulfite Genomic Sequencing
The DNA from 2-5 × 106 resting TH1 or TH2 clone cells and primary cells were collected using the High Pure PCR Template Preparation Kit (Roche) according to the manufacturers’ instructions. One μg of DNA was subjected to bisulfite modification using the CpGenome DNA Modification Kit (Intergen, Purchase, NY) according to the manufacturers’ instructions as published previously (Smith et al., 2006). PCR was performed on 100ng of bisulfite-treated DNA with one of the following primer pairs: Distal: β2ARp-b7 (sense) 5’-GGAGATAGTTGTTRTTTTTAGAATGAG-3’ and β2ARp-b8 (antisense) 5’-ACCCTAACTAAAACACCAAAAAAAA-3’ (299bp product); Proximal: β2ARp-b9 (sense) 5’-TGTTTTAGTTAGGGTAGTTGGAAGG-3’ and β2ARp-b10 (antisense) 5’-AACTATACTAAAATACRTCCTACACA-3’ (315bp product). The PCR products were then cloned and transformed using the TOPO-TA Cloning Kit for Sequencing (Invitrogen) according to the manufacturers’ instructions. DNA samples were then sequenced using an ABI sequencer with Big Dye Terminators (Applied Biosystems). For Wild-type untreated DNA sequencing, the primer sets used were as follows: β2ARp-1P (sense) 5’-CTTATGTGTGTTTCTTTCCTCCTG-3’ and β2ARp-2P (antisense) 5’-GCACCAGAGAGAGAAATCTGG-3’ (positions -581 to -222); β2ARp-3P (sense) 5’-GCAGCCCCAGATTTCTCTCT-3’ and β2ARp-4P (antisense) 5’-GACTCCTGGAAGCTTCATTCA-3’ (positions -248 to 105).
Quantitative real-time PCR
Quantitative real-time PCR was performed as described previously (Podojil and Sanders, 2003). Briefly, a common master mix [LightCycler-FastStartDNA SYBR Green I (Roche, Mannheim, Germany), 2mM MgCl2, 0.5μM gene-specific primer] was used and the concentration of gene-specific cDNA was quantified using a standard curve diluted 1:10 for a concentration range of 1ng/ml to 1fg/ml. A melting curve was generated after each real-time reaction and samples were run on a 1.0% agarose gel to ensure that only one gene-specific PCR product was generated. Real-time PCR was performed using the Roto-gene 2000 Real-time Cycler (Phenix Research Products; Hayward, CA). The following primers were used: β-actin 5’-TACAGCTTCACCACCACAGC-3’ and 5’-AAGGAAGGCTGGAAAAGAGC-3’(annealing temperature, 60°C, 128-bp product); β2AR 5’-TGTTACACCGAGGAGACTTGCTGT-3’ and 5’-TGAGGTTTTGGGCGTGGAATC-3’ (annealing temperature, 58°C); IL-4 5’-CGAAGAACACCACAGAGAGTGAGCT-3’ and 5’-GACTCATTCATGGTGCAGCTTATCG-3’ (annealing temperature, 58°C,180-bp product); and IFN-γ 5’-TTAGCCAAGACTGTGATTGCGG-3’ and 5’-GAGCGAGTTATTTGTCATTCGGG -3’ (annealing temperature, 56°C, 323-bp product).
Statistics
Data were analyzed by ANOVA to determine whether an overall statistically significant change existed. Certain p values were calculated using either a Bonferroni post hoc test for comparison of more than two treatment groups or a Students t test for comparison between two treatment groups. Statistically significant results were determined by a p value of ≤0.05.
To determine whether the two different cell conditions showed different DNA methylation rates, we determined the number of sequence locations that methylation occurred for each cell sample. By using this count as the primary outcome, we assumed a Poisson distribution for the counts. We did one analysis for all the data across the passages of cells (1-6 weeks). The poisson regression model estimated with effect for the TH1 versus TH2 conditions and the effects over weeks of reactivation as well. We also tested an over dispersion parameter to determine whether Poisson assumption was providing too small an error variance. For simplification of interpretation, we also modeled the dichotomy of whether or not methylation occurred at any site using logistic regression. In these models, the treatment condition effects, the passage effects, and the interaction between the two were estimated. This interaction effect estimated the trend in the difference between the two cell conditions as a linear function of the passages. We expected an increasing difference between the two conditions from 1-6 passages. Models were estimated separately for proximal and distal regions. All significance tests were double-sided with alpha0.05. Analyses such as t-tests or repeated measures models were used for other comparisons. Statistically significant results were determined by a p value of ≤0.05.
Results
Differential β2AR mRNA expression
Our laboratory reported that the β2AR is differentially expressed by murine TH1 and TH2 clones (Ramer-Quinn et al., 1997; Sanders et al., 1997), and that the β2AR transcript is detectable in naive CD4+ CD62L+ splenic T (THN) cells (Swanson et al., 2001). To determine if β2AR gene expression was also transcriptionally regulated when murine Th1 and Th2 cells were newly derived from freshly isolated THN cells cultured in vitro for 1-5 days under either TH1 or TH2 promoting conditions using immobilized anti-CD3 and soluble anti-CD28. To confirm that the culture conditions were indeed driving the cells to differentiate to either TH1 or TH2 type cells, we measured IFN-γ and IL-4 mRNA, respectively. The data show that primary THN cells cultured under Th1-promoting conditions increased and maintained the level of β2AR mRNA over 5 days of culture when compared to naive cells (Fig. 1A), which was associated with increased IFN-γ mRNA production (Fig. 1B). In contrast, cells cultured under Th2-promoting conditions initially expressed an increased level of β2AR mRNA that decreased during the subsequent days of culture as IL-4 mRNA production increased (Fig. 1A, C).
Figure 1. β2AR mRNA is expressed in TH1 cells, but not in TH2 cells derived from primary THN cells in vitro.
Naive CD4+ T cells were activated under TH1- and TH2-driving conditions for 0-5 days. Cells were collected each day and total RNA was isolated from TH1 (circles) and TH2 (squares) as well as THN cells (day 0). (A.) β2AR, (B.) IFN-γ and (C.) IL-4 mRNA was measured by quantitative real time PCR. The data were normalized to β-actin and represent the mean mRNA level (fg/ml) ± SEM from three independent experiments.
To determine if more differentiated TH2 cells, as determined by the level of intracellular IL-4 expression, expressed lower levels of β2AR mRNA, cells cultured under TH2-promoting conditions were collected and sorted for high IL-4 expression and low IL-4 expression. Total mRNA was collected from the sorted populations and analyzed for β2AR mRNA expression. The data show that high IL-4-expressing TH2-driven cells transcribed less β2AR mRNA compared to low IL-4-expressing cells (Fig. 2A).
Figure 2. β2AR mRNA expression in sorted and highly differentiated cells in vitro and in vivo.
(A.) Primary effector T cells cultured for 1 week under TH2-driving conditions were sorted for the level of intracellular IL-4 expression. Total RNA was then isolated from low (open bar) and high (closed bar) IL-4-producing cells. (B.) Total RNA was isolated from primary tumor antigen-specific Th1 (C2 and A312, open bars), and Th2 (WB4, closed bar) cells. The level of β2AR and β-actin mRNA was analyzed by quantitative real-time PCR. The data were normalized to β-actin and represent the mean β2AR mRNA (fg/ml) ± SEM from three independent experiments.
To determine if differential β2AR expression occurred under physiological TH1- or TH2-promoting conditions, we measured the level of β2AR mRNA expression in TH1 and TH2 cell lines that were generated to afford protection against a specific tumor antigen in vivo. In vivo clearance of a reticulum cell sarcoma (RCSX) tumor is dependent on the ability of CD4+ T cells to interact and recruit leukocytes that participate in tumor clearance (Simmons et al., 2005). The IFN-γ-producing TH1 cell lines, C2 and A312, and the IL-4-producing TH2 cell line WB4 were selected for their ability to recognize γ-irradiated lymphoma cells in vitro, as well as their ability to recognize RCSX tumor cells in vivo (Simmons et al., 2005). Following re-activation of the cell lines in vitro, total mRNA was isolated and analyzed for the level of cytokine and β2AR mRNA expression using quantitative real time PCR (Fig. 2B). A higher level of β2AR mRNA expression was detected in IFN-γ-producing C2 and A312 cells as compared to the very low level detected in IL-4-producing WB4 cells.
Histone modifications in the ββ2AR promoter
Histone modification is a well-studied mechanism of gene regulation. Acetylation of histones 3 and 4 occurs on many residues and is mediated by histone acetyltransferases (HATs) and histone deacetylases (HDACs) (Strahl and Allis, 2000). Most data suggest that acetylation of H3 and H4 plays a fundamental role in regulating gene transcription while unacetylated DNA is silenced (Kornberg and Lorch, 1999; Struhl, 1998). Acetylation of specific lysine residues varies from gene to gene and throughout cell development, thus we examined the pan-acetylation status of H3 and H4. The level of total H3 or H4 acetylation in TH1 and TH2 cultures was examined in cells after one week in culture was variable (data not shown). However, cells from either TH1- or TH2-promoting conditions sorted for IFN-γ or IL-4 protein expression, respectively, revealed a distinct level of pan-H3 and H4 acetylation when compared to THN cells (Fig. 3). TH2 cells, which do not express the β2AR, had low levels of H3 acetylation (Fig. 3A) and no detectable levels of H4 acetylation (Fig. 3B) when compared to TH1 cells, which do express the β2AR. Interestingly, THN cells expressed low levels of H3 acetylation and relatively high levels of H4 acetylation. These findings suggest that histones in the β2AR promoter of the THN and TH1 cells are acetylated, which opens the β2AR gene to transcription, while the TH2 cells have very little H3 or H4 acetylation, which has been associated with a lack of transcription.
Figure 3. Histone acetylation changes in the β2AR promoter in TH1- and TH2-driven CD4+ T cells.
(A.) Primary effector T cells cultured for 1 week under TH1- or TH2-driving conditions were sorted for the level of intracellular IFN-γ or IL-4 protein expression, respectively. Cells were collected, fixed, and analyzed by ChIP for pan (A.) H3 or (B.) H4 acetylation. Isolated DNA was analyzed by PCR and agarose gel separation for the β2AR promoter. Data from one representative experiment of two independent experiments is presented as the fold difference from naive levels of acetylation. BLD, Below Level of Detection.
More specifically, histone methylation is a very early mechanism by which cytokine expression is regulated in differentiating TH1 and TH2 cells (Chang and Aune, 2007). Surprisingly, some of these changes can be detected within hours to days after initial CD4+ T cell exposure to TH1- or TH2-promoting conditions, which was previously described in the promoters for Ifng and Il4 (Chang and Aune, 2007). To determine if histone methylation changes were occurring within the β2AR promoter region, we used ChIP to examine the methylation level of H3K4, which is associated with open chromatin, and H3K9 and H3K27, which are associated with closed chromatin. Because the peak changes in the cytokine genes occurred at 3 days of culture in TH1- or TH2-promoting conditions, we examined histone changes in the β2AR promoter on day 3. Uncultured THN cells contained a low level of both H3K4 and H3K9 methylation within the β2AR promoter (Fig. 4A, B). CD4+ T cells cultured under TH1-promoting conditions showed enriched H3K4 methylation (Fig. 4A) while cells cultured under TH2-promoting conditions showed enriched H3K9 methylation in the β2AR promoter region after 3 days of culture (Fig. 4B). Methylation of H3K27 was only detected in cells cultured under TH2-promoting conditions (Fig. 4B). These findings suggest that methylation of the histones may be an early mechanism by which expression or repression of the β2AR gene is mediated.
Figure 4. Histone methylation changes in the β2AR promoter in TH1- and TH2-driven CD4+ T cells.
Primary naive CD4+ T cells were cultured under TH1- or TH2-promoting conditions as described previously. Before culture (THN, gray bars) or after three days of culture (TH1, white bars; TH2, black bars), cells were collected, fixed, and analyzed by ChIP for (A.) H3K4 (open chromatin) and (B.) H3K9/H3K27 (closed chromatin) dimethylation. Isolated DNA was analyzed by PCR and agarose gel separation for the β2AR promoter. Data from three independent experiments are presented as the level of histone methylation normalized to the input DNA control sample ± SEM. BLD, Below Level of Detection.
Methylation of CpG Dinucleotides in the β2AR promoter
Along with histone modifications, DNA methylation of CpG dinucleotides is a more permanent mechanism by which the activity of a specific promoter is regulated (Hmadcha et al., 1999; Holliday and Pugh, 1975; Kang et al., 1999). To determine if differential methylation of CpG dinucleotides within the β2AR promoter occurred in TH1 and TH2 cells, 3 experimental approaches were used, namely methylation-sensitive restriction endonuclease (MSRE) digestion, methyl-sensitive PCR (MSP) of the β2AR promoter, and bisulfite genomic sequencing. Preliminary results using MSRE and MSP indicated that methylation of CpG dinucleotides within both the proximal (location -181 to 56) and distal (-481 to -196) regions of the promoter the β2AR promoter occurred in TH2, but not TH1 cells (data not shown). To confirm the MSRE and MSP data that indicated DNA methylation had occurred and to identify the locations of methylated CpG dinucleotide pairs within the β2AR promoter region, we used bisulfite genomic sequencing to analyze T cell clones and primary T cells cultured in TH1- or TH2-driving conditions for several weeks. The data revealed a distinct pattern of CpG dinucleotide methylation in both the proximal (location -181 to 56) region of the promoter, as well as within the transcription start site (map shown in Fig. 5A). Analysis of T cell clones showed that the cytosine residues were methylated in TH2, but not TH1 clones, while the level of CpG dinucleotide methylation was undetectable in THN (Fig. 5B). In contrast to the striking difference found in the pattern of CpG dinucleotide methylation in T cell clones, the pattern was not as distinct in primary effector cells. However, the level of methylation in primary TH2 cells was significantly greater than that measured in primary TH1 cells (p=0.036) (Fig. 5B). The mean frequency of methylation was 3 times larger in the TH2 cells as compared to TH1 cells within the proximal region (Fig. 5B). The proximal (Fig. 5B) region of the β2AR promoter expressed a low level of methylation throughout several weeks of re-activation, and no passage by culture interaction was found. Taken together, these data identify CpG dinucleotide methylation in the β2AR promoter sequence of primary TH2 cells and clones, suggesting that this may be the mechanism by which permanent repression of the β2AR gene is induced.
Figure 5. CpG dinucleotides in the proximal β2AR promoter show an increased rate of methylation in TH2 cells as compared to TH1 cells.
(A.) Schematic of the β2AR gene and proximal promoter region (-181 to +56) that contains 19 CpG dinucleotides and was amplified by the primer set β2ARp-b9/b10 (B.) DNA was isolated from the resting TH1 cell clones D1.1, HDK, AR100.9 and the resting TH2 cell clones CDC35, LNT-1, LNT-4, bisulfite treated, and the proximal β2AR promoter was sequenced. Murine naive CD4+ T cells were activated as described previously. Cells were reactivated weekly for 4-5 weeks under polarizing conditions. DNA was isolated from naive T cells and each week from TH1 and TH2 cells, bisulfite treated, and analyzed as with the T cell clones. Each circle is representative of a CpG dinucleotide within the proximal β2AR promoter. Open and filled circles represent unmethylated or methylated status of the CpG dinucleotide, respectively. Data are representative of 6 to 10 cloned sequences.
Discussion
Gene silencing mediated by epigenetic mechanisms is important for regulating appropriate gene expression as a cell differentiates during early development (Li, 2002). As a naive CD4+ T cell differentiates post-developmentally, epigenetic mechanisms are activated to promote appropriate cytokine gene expression in resulting TH1 and TH2 cells (Baguet and Bix, 2004; Chang and Aune, 2005, 2007; Zhou et al., 2004). We hypothesized and show for the first time in the present study that similar changes occur in the β2AR promoter during CD4+ T cell differentiation to either a TH1 or TH2 and include modifiable (histone modifications) and more permanent (DNA methylation) epigenetic changes.
To test these hypotheses, we examined histone modifications as well as DNA methylation during CD4+ T cell differentiation. These data show that within the β2AR proximal promoter H3K9 and H3K27 dimethylation and the frequency of methylated CpG dinucleotides (both modifications are classically indicative of closed chromatin) increased in TH2 cells as compared to THN and TH1 cells. In contrast, TH1 cells showed an increase in pan-H3/H4 acetylation and H3K4 dimethylation, which are indicative of open chromatin, and very little DNA methylation when compared to THN and TH2 cells. Taken together, these findings suggest that chromatin remodeling in the β2AR gene promoter is one of the mechanisms by which β2AR gene expression is regulated in CD4+ T cells as they differentiate under TH1- or TH2-driving conditions.
Our observations revealed a pattern of histone methylation that is not entirely black or white. While pan-H3/H4 acetylation and H3K4 dimethylation are associated with open chromatin and gene expression, these modifications are not entirely absent within the β2AR promoter in TH2 cells, which lack β2AR expression. Conversely, H3K9 dimethylation is more often associated with closed chromatin and gene repression, yet this modification is still detectable at low levels in the TH1 cells, which express the β2AR. These methylation findings may be due to the analysis in the present study of unsorted populations of cells in which undifferentiated cells were still present. While the culture conditions are intended to drive the cells towards a TH1 or TH2 phenotype, we determined by flow cytometry that this is not the case for all cells (data not shown). In addition, several other types of histone modifications, such as acetylation, phosphorylation, ribosylation, and ubiquitination (Eberharter and Becker, 2002; Jaenisch and Bird, 2003; Mutskov and Felsenfeld, 2004) may also be occurring as a mechanism to control expression of the β2AR. Our data on pan-H3/H4 acetylation, which is often associated with gene transcription, was more prevalent in TH1-driven and sorted cells while it was nearly absent inTH2- driven and sorted cell populations. Ultimately, a pattern of distinct histone modifications would create a ‘histone code’ to determine chromatin remodeling and gene expression (Strahl and Allis, 2000).
Bird and colleagues demonstrated that histone modifications of cytokine genes are cell-cycle dependent and that an increased number of cell divisions is required for TH2 differentiation as compared to TH1 differentiation (Bird et al., 1998). Our results are consistent with this report because, like the histone modification data, the level of β2AR mRNA was not reduced to undetectable levels, even in sorted populations or tumor-driven (comparable to in vitro re-stimulated) cells, indicating that the cells may not be fully differentiated. Furthermore, following multiple weeks of in vitro culture under TH2-driving conditions (data not shown), the level of β2AR mRNA remained at low, but detectable levels, as well. In addition, we found that DNA methylation in the β2AR promoter was variable and inconsistent in TH2-driven cells, although significant after several weeks of re-stimulation. Incomplete differentiation would be even more discernable when examining human CD4+ T cells, as several studies have suggested that human T cells do not differentiate to the degree of murine T cells (Abbas et al., 1996; Romagnani, 1994, 2000). Our data from cells differentiated in vitro by TH1- or TH2-driving tumors (Fig. 2B) suggests that the greatest levels of differentiation may be reached during disease states and that during these disease states, proper differentiation of CD4+ T cells and proper expression of the β2AR may be of utmost importance.
The epigenetic changes measured within the β2AR proximal promoter in the present study occurred in THN cells that were activated under conditions that differed only in the cytokines introduced to direct differentiation, i.e., IL-12 and IL-4 for TH1 and TH2 differentiation, respectively. This difference suggests, but does not prove, that IL-12 and IL-4, as well as possibly the IFN-γ released by the developing TH1 cells, may activate specific transcription factors that participate in promoting the chromatin remodeling that is associated with differential expression of β2AR mRNA and protein by TH1 and TH2 cells. However, the mechanism responsible for linking these events is unknown. The chromatin remodeling that is associated with both cytokine gene expression and repression in TH1 and TH2 cells is promoted by the activation of the transcription factor GATA3 by IL-4 (Lee et al., 2001; Lee et al., 2003), STAT-4 by IL-12, and/or STAT1 and T-bet by IFN-γ (Lee et al., 2006; Murphy and Reiner, 2002). Our findings suggest that the absence or presence of IL-12, IFN-γ, and IL-4 are associated with the onset of chromatin modifications within the β2AR promoter of developing TH1 and TH2 cells. Therefore, it is possible that the transcription factors activated by these cytokines might also play a role in promoting the onset of chromatin modifications that occur within the β2AR promoter of each effector subset.
The physiological relevance for differential β2AR expression by TH1 and TH2 cells is unknown. However, stimulation of the β2AR on either the effector TH1 cell or the naive CD4+ T cells cultured under TH1-driving conditions causes a change to occur in the level of IFN-γ produced (Ramer-Quinn et al., 2000; Swanson et al., 2001). If such changes occurred under physiological conditions, e.g. if the neurotransmitter NE, which is the endogenous ligand for the β2AR, is released during times of stress or upon antigen exposure (Kohm et al., 2000) and causes an increase in the level of IFN-γ within the microenvironment of an activated THN cell, then this might influence the direction of naive CD4+ T cell differentiation and/or the subsequent development of TH1-biased pathologies, including inflammation, tissue damage, and autoimmune diseases (Firestein, 2003). Thus, understanding a mechanism that exists for regulating the level of expression for the β2AR might prove useful. Furthermore, since the elevation of cAMP within a TH2 cell is reported to increase the level of IL-4 produced (Lacour et al., 1994), a β2AR-induced increase in cAMP in TH2 cells might exacerbate an IL-4-dependent response (Fedyk et al., 1996), such as might occur during allergic asthma when an individual either is stressed and norepinephrine is released at a higher level than level or is using a β2AR agonist for bronchodialation therapy. Thus, understanding the epigenetic mechanisms that regulate β2AR expression may lead to the development of novel targeted therapies for limiting or enhancing TH1 and TH2 cell responsiveness to norepinephrine or a β2AR agonist. In addition, such an understanding may provide one more tool with which to therapeutically regulate the development and progression of various TH1- and TH2-mediated pathologies, and perhaps provide insight into novel mechanisms by which β2AR expression might be regulated in cells outside of the immune system itself.
Figure 6. Epigenetic changes in the proximal β2AR promoter.
Naive CD4+ T cells activated in the presence of IL-12 or IL-4 will differentiate into TH1 or TH2, respectively. As these cells differentiate, the histones and DNA of the proximal β2AR promoter will undergo many changes. In a TH1 cell (left side of figure), the tail of histones 3 and 4 will become acetylated at several amino acids and the tail of histone 3 will become methylated at residue Lysine 4. In addition, the chromatin will remain open and unmethylated, allowing access to transcription factors that can bind to the DNA to increase transcription and ultimately expression of the β2AR on the TH1 cell. In a TH2 cell (right side of figure), the tail of histones 3 and 4 will be stripped of any acetylation and residues Lysine 9 and 27 will be methylated. The chromatin will be closed and become methylated, which decreases DNA access to transcription factors and results in decreased β2AR transcription and expression on the TH2 cell.
Acknowledgements
This study was supported by research funding from NIH AI37326 to V.M.S.; NIH T32 AI55411 to J.W.M. Dr. Adam Kohm, former graduate student of the Sanders Lab, provided preliminary data for the study. Paula Sharp and Christopher Burnsides, research technicians, provided technical assistance for the study.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of interest statement: All authors declare there are no conflicts of interest
Subject Category: Chromatin & Transcription; Immunology
References
- Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383:787–793. doi: 10.1038/383787a0. [DOI] [PubMed] [Google Scholar]
- Agarwal S, Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity. 1998;9:765–775. doi: 10.1016/s1074-7613(00)80642-1. [DOI] [PubMed] [Google Scholar]
- Avni O, Lee D, Macian F, Szabo SJ, Glimcher LH, Rao A. Th cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol. 2002;3:643–651. doi: 10.1038/ni808. [DOI] [PubMed] [Google Scholar]
- Baguet A, Bix M. Chromatin landscape dynamics of the Il4-Il13 locus during T helper 1 and 2 development. Proc Natl Acad Sci U S A. 2004;101:11410–11415. doi: 10.1073/pnas.0403334101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bergman Y, Cedar H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nat Rev Immunol. 2004;4:753–761. doi: 10.1038/nri1458. [DOI] [PubMed] [Google Scholar]
- Bilic I, Koesters C, Unger B, Sekimata M, Hertweck A, Maschek R, Wilson CB, Ellmeier W. Negative regulation of CD8 expression via Cd8 enhancer-mediated recruitment of the zinc finger protein MAZR. Nat Immunol. 2006 doi: 10.1038/ni1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bird JJ, Brown DR, Mullen AC, Moskowitz NH, Mahowald MA, Sider JR, Gajewski TF, Wang CR, Reiner SL. Helper T cell differentiation is controlled by the cell cycle. Immunity. 1998;9:229–237. doi: 10.1016/s1074-7613(00)80605-6. [DOI] [PubMed] [Google Scholar]
- Chang S, Aune TM. Histone hyperacetylated domains across the Ifng gene region in natural killer cells and T cells. Proc Natl Acad Sci U S A. 2005;102:17095–17100. doi: 10.1073/pnas.0502129102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang S, Aune TM. Dynamic changes in histone-methylation ‘marks’ across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells. Nat Immunol. 2007;8:723–731. doi: 10.1038/ni1473. [DOI] [PubMed] [Google Scholar]
- Eberharter A, Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 2002;3:224–229. doi: 10.1093/embo-reports/kvf053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eivazova ER, Aune TM. Dynamic alterations in the conformation of the Ifng gene region during T helper cell differentiation. Proc Natl Acad Sci U S A. 2004;101:251–256. doi: 10.1073/pnas.0303919101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fedyk ER, Adawi A, Looney RJ, Phipps RP. Regulation of IgE and cytokine production by cAMP: implications for extrinisic asthma. Clin. Immunol. Immunopharmacol. 1996;81:101–113. doi: 10.1006/clin.1996.0165. [DOI] [PubMed] [Google Scholar]
- Felten SY, Madden KS, Bellinger DL, Kruszewska B, Moynihan JA, Felten DL. The role of the sympathetic nervous system in the modulation of immune responses. Adv Pharmacol. 1998;42:583–587. doi: 10.1016/s1054-3589(08)60818-2. [DOI] [PubMed] [Google Scholar]
- Felten SY, Olschowka J. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J.Neurosci.Res. 1987;18:37–48. doi: 10.1002/jnr.490180108. [DOI] [PubMed] [Google Scholar]
- Fields PE, Kim ST, Flavell RA. Cutting edge: changes in histone acetylation at the IL-4 and IFN-gamma loci accompany Th1/Th2 differentiation. J Immunol. 2002;169:647–650. doi: 10.4049/jimmunol.169.2.647. [DOI] [PubMed] [Google Scholar]
- Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–361. doi: 10.1038/nature01661. [DOI] [PubMed] [Google Scholar]
- Hmadcha A, Bedoya FJ, Sobrino F, Pintado E. Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J.Exp.Med. 1999;190:1595–1604. doi: 10.1084/jem.190.11.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holliday R, Pugh JE. DNA modification mechanisms and gene activity during development. Science. 1975;187:226–232. [PubMed] [Google Scholar]
- Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(Suppl):245–254. doi: 10.1038/ng1089. [DOI] [PubMed] [Google Scholar]
- Kang SH, Bang YJ, Im YH, Yang HK, Lee DA, Lee HY, Lee HS, Kim NK, Kim SJ. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer. Oncogene. 1999;18:7280–7286. doi: 10.1038/sj.onc.1203146. [DOI] [PubMed] [Google Scholar]
- Kohm AP, Sanders VM. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev. 2001;53:487–525. [PubMed] [Google Scholar]
- Kohm AP, Tang Y, Sanders VM, Jones SB. Activation of antigen-specific CD4+ Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow. J.Immunol. 2000;165:725–733. doi: 10.4049/jimmunol.165.2.725. [DOI] [PubMed] [Google Scholar]
- Kornberg RD, Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell. 1999;98:285–294. doi: 10.1016/s0092-8674(00)81958-3. [DOI] [PubMed] [Google Scholar]
- Lacour M, Arrighi JF, Muller KM, Carlberg C, Saurat JH, Hauser C. cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. Int.Immunol. 1994;6:1333–1343. doi: 10.1093/intimm/6.9.1333. [DOI] [PubMed] [Google Scholar]
- Lee DU, Agarwal S, Rao A. Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity. 2002;16:649–660. doi: 10.1016/s1074-7613(02)00314-x. [DOI] [PubMed] [Google Scholar]
- Lee GR, Fields PE, Flavell RA. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity. 2001;14:447–459. doi: 10.1016/s1074-7613(01)00125-x. [DOI] [PubMed] [Google Scholar]
- Lee GR, Fields PE, Griffin TJ, Flavell RA. Regulation of the Th2 cytokine locus by a locus control region. Immunity. 2003;19:145–153. doi: 10.1016/s1074-7613(03)00179-1. [DOI] [PubMed] [Google Scholar]
- Lee GR, Kim ST, Spilianakis CG, Fields PE, Flavell RA. T helper cell differentiation: regulation by cis elements and epigenetics. Immunity. 2006;24:369–379. doi: 10.1016/j.immuni.2006.03.007. [DOI] [PubMed] [Google Scholar]
- Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet. 2002;3:662–673. doi: 10.1038/nrg887. [DOI] [PubMed] [Google Scholar]
- Makar KW, Perez-Melgosa M, Shnyreva M, Weaver WM, Fitzpatrick DR, Wilson CB. Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat Immunol. 2003;4:1183–1190. doi: 10.1038/ni1004. [DOI] [PubMed] [Google Scholar]
- Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code? Curr. Opin. Genet. Dev. 2005;15:163–176. doi: 10.1016/j.gde.2005.01.005. [DOI] [PubMed] [Google Scholar]
- Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol. 2002;2:933–944. doi: 10.1038/nri954. [DOI] [PubMed] [Google Scholar]
- Mutskov V, Felsenfeld G. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. Embo J. 2004;23:138–149. doi: 10.1038/sj.emboj.7600013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Podojil JR, Kin NW, Sanders VM. CD86 and beta2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B Expression and binding to the 3'-IgH enhancer in B cells. J.Biol.Chem. 2004;279:23394–23404. doi: 10.1074/jbc.M313096200. [DOI] [PubMed] [Google Scholar]
- Podojil JR, Sanders VM. Selective regulation of mature IgG1 transcription by CD86 and beta2-adrenergic receptor stimulation. J.Immunol. 2003;170:5143–5151. doi: 10.4049/jimmunol.170.10.5143. [DOI] [PubMed] [Google Scholar]
- Ramer-Quinn DS, Baker RA, Sanders VM. Activated Th1 and Th2 cells differentially express the beta-2-adrenergic receptor: A mechanism for selective modulation of Th1 cell cytokine production. J.Immunol. 1997;159:4857–4867. [PubMed] [Google Scholar]
- Ramer-Quinn DS, Swanson MA, Lee WT, Sanders VM. Cytokine production by naive and primary effector CD4(+) T cells exposed to norepinephrine. Brain Behav.Immun. 2000;14:239–255. doi: 10.1006/brbi.2000.0603. [DOI] [PubMed] [Google Scholar]
- Romagnani S. Lymphokine production by human T cells in disease states. Ann.Rev.Immunol. 1994;12:227–257. doi: 10.1146/annurev.iy.12.040194.001303. [DOI] [PubMed] [Google Scholar]
- Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy. Asthma. Immunol. 2000;85:9–18. doi: 10.1016/S1081-1206(10)62426-X. quiz 18, 21. [DOI] [PubMed] [Google Scholar]
- Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE. Differential expression of the beta-2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help. J.Immunol. 1997;158:4200–4210. [PubMed] [Google Scholar]
- Simmons WJ, Koneru M, Mohindru M, Thomas R, Cutro S, Singh P, Dekruyff RH, Inghirami G, Coyle AJ, Kim BS, Ponzio NM. Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms. J Immunol. 2005;174:1405–1415. doi: 10.4049/jimmunol.174.3.1405. [DOI] [PubMed] [Google Scholar]
- Smith LT, Lin M, Brena RM, Lang JC, Schuller DE, Otterson GA, Morrison CD, Smiraglia DJ, Plass C. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci U S A. 2006;103:982–987. doi: 10.1073/pnas.0510171102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steinman L. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 2004;5:575–581. doi: 10.1038/ni1078. [DOI] [PubMed] [Google Scholar]
- Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41–45. doi: 10.1038/47412. [DOI] [PubMed] [Google Scholar]
- Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 1998;12:599–606. doi: 10.1101/gad.12.5.599. [DOI] [PubMed] [Google Scholar]
- Swanson MA, Lee WT, Sanders VM. IFN-gamma Production by Th1 Cells Generated from Naive CD4(+) T Cells Exposed to Norepinephrine. J. Immunol. 2001;166:232–240. doi: 10.4049/jimmunol.166.1.232. [DOI] [PubMed] [Google Scholar]
- Taniuchi I, Sunshine MJ, Festenstein R, Littman DR. Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation. Mol Cell. 2002;10:1083–1096. doi: 10.1016/s1097-2765(02)00735-9. [DOI] [PubMed] [Google Scholar]
- Zhou W, Chang S, Aune TM. Long-range histone acetylation of the Ifng gene is an essential feature of T cell differentiation. Proc Natl Acad Sci U S A. 2004;101:2440–2445. doi: 10.1073/pnas.0306002101. [DOI] [PMC free article] [PubMed] [Google Scholar]






